Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CDMO Avid Bioservices, Inc.

盘前交易 05-01 08:23:09 EDT

7.63

+0.07

+0.93%

盘前7.62

-0.01-0.13%

08:11 EDT

最高7.83	最低7.25	成交量121.09万
今开7.40	昨收7.56	日振幅7.67%
总市值4.84亿	流通市值4.22亿	总股本6,348万
成交额923.25万	换手率2.19%	流通股本5,535万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":7.63,"timestamp":1714507200000,"preClose":7.56,"halted":0,"volume":1210944,"hourTrading":{"tag":"盘前","latestPrice":7.62,"preClose":7.63,"latestTime":"08:11 EDT","volume":100,"amount":762,"timestamp":1714565490742},"delay":0,"floatShares":55347981,"shares":63479794,"eps":-0.280812,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.07,"latestTime":"05-01 08:23:09 EDT","open":7.4,"high":7.83,"low":7.25,"amount":9232539.792,"amplitude":0.07672,"askPrice":8.28,"askSize":100,"bidPrice":6.55,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.280812,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714570200000},"adr":0,"adjPreClose":7.63,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.62,"preClose":7.63,"latestTime":"08:11 EDT","volume":100,"amount":762,"timestamp":1714565490742},"postHourTrading":{"tag":"盘后","latestPrice":7.63,"preClose":7.63,"latestTime":"17:30 EDT","volume":188401,"amount":1437497.63,"timestamp":1714512600502},"volumeRatio":0.894659367970551},"requestUrl":"/m/hq/s/CDMO/wiki","defaultTab":"wiki","newsList":[{"id":"2432530641","title":"加拿大皇家银行：维持Avid Bioservices(CDMO.US)评级，由优于大市调整至优于大市评级, 目标价由7.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432530641","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432530641?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:14","pubTimestamp":1714497286,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持Avid Bioservices(CDMO.US)评级，由优于大市调整至优于大市评级, 目标价由7.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010114478b671d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010114478b671d09&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431739300","title":"美国研究综述-多米诺比萨、HCA 医疗保健、WW Grainger","url":"https://stock-news.laohu8.com/highlight/detail?id=2431739300","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431739300?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:46","pubTimestamp":1714466797,"startTime":"0","endTime":"0","summary":"    路透4月30日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，包括多米诺比萨、HCA 医疗保健和 WW Grainger 。要点  * 多米诺比萨公司  ：BTIG将目标价从515美元上调至580美元 * HCA Healthcare Inc   ：TD Cowen将目标价从371美元下调至360美元 * Molina Healthcare Inc   ：TD Cowen将目标价从453美元下调至412美元 * 屈臣氏  ：摩根大通将目标价从350美元上调至400美元 * WW Grainger Inc   ：Stephens将目标价从1000美元上调至1250美元 以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431813638","title":"Avid Bioservices, Inc.盘中异动 大幅拉升5.17%报7.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431813638","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431813638?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:51","pubTimestamp":1714409484,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日00时51分，Avid Bioservices, Inc.股票出现波动，股价快速拉升5.17%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000512479250a8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043000512479250a8c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430226706","title":"Nitto Denko Avecia Inc. 新总裁上任","url":"https://stock-news.laohu8.com/highlight/detail?id=2430226706","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2430226706?lang=zh_cn&edition=full","pubTime":"2024-04-28 10:39","pubTimestamp":1714271940,"startTime":"0","endTime":"0","summary":"马萨诸塞州米尔福德2024年4月28日 /美通社/ --寡核苷酸疗法委托开发和制造的全球市场领军者 Nitto Denko Avecia Inc. 和 Nitto Denko Avecia Pharma Services  于今日宣布，Tammy Cooper 将于 2024 年 6 月 21 日起被正式任命为 Nitto Avecia 总裁。目前，Cooper 女士是 Nitto Avecia 的业务开发和项目管理副总裁。作为总裁，她将隶属于 Yoshihiko Terada；后者将被任命为 Nitto Avecia 的执行董事长。Terada 先生在 Nitto Denko 工作了九年，曾担任 Nitto Avecia 的办公厅主任和 Nitto Denko 公司副总裁。Nitto Denko 致力于以客户为导向的方式进行创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4398341_ZH98341_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430550682","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430550682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430550682?lang=zh_cn&edition=full","pubTime":"2024-04-26 03:42","pubTimestamp":1714074141,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日03时42分，Lifecore Biomedical, Inc.股票出现波动，股价急速拉升5.21%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.71%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042603422287e83d6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042603422287e83d6b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430371782","title":"Avid Bioservices, Inc.盘中异动 下午盘急速拉升5.27%报7.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430371782","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430371782?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:54","pubTimestamp":1714067677,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日01时54分，Avid Bioservices, Inc.股票出现异动，股价快速上涨5.27%。截至发稿，该股报7.19美元/股，成交量95.8438万股，换手率1.51%，振幅6.59%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042601543787e83d47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042601543787e83d47&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430491182","title":"Avid Bioservices Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2430491182","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430491182?lang=zh_cn&edition=full","pubTime":"2024-04-25 05:38","pubTimestamp":1713994708,"startTime":"0","endTime":"0","summary":"   * Avid Bioservices Inc   报告了截至1月底的季度调整后每股亏损9美分，低于去年同期的每股收益1美分。五位分析师对该季度的平均预期是每股亏损 5 美分。华尔街预期为每股-7美分至-3美分。* Avid Bioservices Inc公布的本季度每股收益为亏损9美分。* 该公司的季度亏损额为 601 万美元。* Avid Bioservices Inc 本季度股价下跌了 0.3%，今年迄今为止上涨了 2.8%。4月24日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 5%。华尔街对 Avid Bioservices Inc 的 12 个月目标价中位数为 13.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429146811","title":"Avid Bioservices, Inc.盘中异动 下午盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429146811","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429146811?lang=zh_cn&edition=full","pubTime":"2024-04-24 02:17","pubTimestamp":1713896239,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日02时17分，Avid Bioservices, Inc.股票出现异动，股价急速拉升5.15%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体涨幅为1.67%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240217197922b785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240217197922b785&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429973416","title":"Lifecore Biomedical, Inc.盘中异动 早盘急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429973416","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429973416?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:23","pubTimestamp":1713799414,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时23分，Lifecore Biomedical, Inc.股票出现波动，股价急速跳水5.08%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.40%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一个完全集成的合同开发和制造组织，提供高度差异化的能力，在注射器和小瓶的复杂无菌可注射药物产品的开发，填充和完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222323357a549bfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222323357a549bfd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428692020","title":"Avid Bioservices Inc   预计每股亏损5美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2428692020","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428692020?lang=zh_cn&edition=full","pubTime":"2024-04-20 06:08","pubTimestamp":1713564535,"startTime":"0","endTime":"0","summary":"   * Avid Bioservices Inc    预计将在4月22日公布截至2024年1月31日的季度业绩(预计)，季度收入将出现下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州塔斯廷的公司的营收预计将从去年同期的3802万美元下降12.0%，至3345.2万美元。* LSEG分析师对Avid Bioservices公司的平均预期是每股亏损5美分。* 华尔街对 Avid Bioservices Inc 的 12 个月目标价中位数为 13.00 美元，高于其上次收盘价 6.52 美元。4月19日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428664189","title":"Lifecore Biomedical, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428664189","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428664189?lang=zh_cn&edition=full","pubTime":"2024-04-20 01:08","pubTimestamp":1713546502,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日01时08分，Lifecore Biomedical, Inc.股票出现波动，股价大幅上涨5.15%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为1.18%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一个完全集成的合同开发和制造组织，提供高度差异化的能力，在注射器和小瓶的复杂无菌可注射药物产品的开发，填充和完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200108227921ebd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200108227921ebd1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428968260","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428968260","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428968260?lang=zh_cn&edition=full","pubTime":"2024-04-19 00:04","pubTimestamp":1713456279,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日00时04分，Lifecore Biomedical, Inc.股票出现异动，股价急速跳水5.05%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.09%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一个完全集成的合同开发和制造组织，提供高度差异化的能力，在注射器和小瓶的复杂无菌可注射药物产品的开发，填充和完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419000439861e71ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419000439861e71ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428869806","title":"Avid Bioservices, Inc.盘中异动 大幅上涨5.15%报7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428869806","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428869806?lang=zh_cn&edition=full","pubTime":"2024-04-17 02:08","pubTimestamp":1713290890,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日02时08分，Avid Bioservices, Inc.股票出现波动，股价急速拉升5.15%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041702081087e8105e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041702081087e8105e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427871454","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427871454","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427871454?lang=zh_cn&edition=full","pubTime":"2024-04-16 23:22","pubTimestamp":1713280975,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日23时22分，Lifecore Biomedical, Inc.股票出现异动，股价快速拉升5.28%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.63%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一个完全集成的合同开发和制造组织，提供高度差异化的能力，在注射器和小瓶的复杂无菌可注射药物产品的开发，填充和完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416232256861e65a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416232256861e65a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427882871","title":"消息称 EnQuest 出售北海金鹰油田股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2427882871","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427882871?lang=zh_cn&edition=full","pubTime":"2024-04-16 19:35","pubTimestamp":1713267309,"startTime":"0","endTime":"0","summary":" Ron Bousso/Deep Kaushik Vakil    路透社伦敦4月16日 - 两位消息人士周二告诉路透社，英国EnQuest   公司正寻求出售其在英国北海金鹰油田27%的股份，以降低债务水平。EnQuest发言人拒绝发表评论。2022 年俄罗斯入侵乌克兰后，能源价格暴涨，英国对北海生产商征收 35% 的暴利税，EnQuest 近年来陷入困境，债务水平居高不下，利润下降。EnQuest 还在 3 月份宣布了首次股东分配，即在 2024 年回购 1500 万美元的股票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427862989","title":"港股异动 | 金斯瑞生物科技(01548)跌超5% 公司股价创近几年来新低 CDMO短期需求增长及盈利能力承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2427862989","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427862989?lang=zh_cn&edition=full","pubTime":"2024-04-16 11:05","pubTimestamp":1713236748,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，金斯瑞生物科技跌超5%，截止发稿跌5.59%，报11.48港元，成交额1.04亿港元，盘中股价续创近几年来新低。国泰君安表示，公司非细胞疗法业务贡献净利润稳步增长，CAR-T产品在欧美快速放量。此外，中金近日指出，考虑到CDMO短期需求增长及盈利能力承压，下调2024年盈利预测至净亏损1.97亿美元，同时引入2025年盈利预测净亏损0.90亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103115.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427976865","title":"Avid Bioservices Inc   预计每股亏损5美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2427976865","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427976865?lang=zh_cn&edition=full","pubTime":"2024-04-13 04:47","pubTimestamp":1712954836,"startTime":"0","endTime":"0","summary":"   * Avid Bioservices Inc    预计将在4月15日公布截至2024年1月31日的季度业绩(预计)，季度收入将出现下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州塔斯廷的公司的营收预计将从去年同期的3802万美元下降12.0%，至3345.2万美元。* LSEG分析师对Avid Bioservices公司的平均预期是每股亏损5美分。* 华尔街对 Avid Bioservices Inc 的 12 个月目标价中位数为 13.00 美元，高于其最新收盘价 6.90 美元。4月12日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426951228","title":"云舟生物冲刺科创板IPO：募资扩产是否遭遇CDMO产能过剩？","url":"https://stock-news.laohu8.com/highlight/detail?id=2426951228","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2426951228?lang=zh_cn&edition=full","pubTime":"2024-04-12 11:02","pubTimestamp":1712890942,"startTime":"0","endTime":"0","summary":"买楼扩产","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/ceb55d1d-5edc-4658-b51a-c8fbbbb8dac3.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/ceb55d1d-5edc-4658-b51a-c8fbbbb8dac3.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3712561","is_publish_highlight":false,"gpt_icon":0},{"id":"2426492674","title":"Avid Bioservices, Inc.盘中异动 股价大跌6.95%报6.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426492674","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426492674?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:34","pubTimestamp":1712756051,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时34分，Avid Bioservices, Inc.股票出现异动，股价快速跳水6.95%。截至发稿，该股报6.69美元/股，成交量4.25万股，换手率0.07%，振幅2.23%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213412876169b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213412876169b3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426035925","title":"Avid Bioservices, Inc.盘中异动 临近收盘急速上涨5.05%报6.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426035925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426035925?lang=zh_cn&edition=full","pubTime":"2024-04-09 03:50","pubTimestamp":1712605803,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日03时50分，Avid Bioservices, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报6.66美元/股，成交量29.7471万股，换手率0.47%，振幅5.21%。Avid Bioservices, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Avid Bioservices, Inc.公司简介：Avid Bioservices Inc是一家临床阶段的生物制药公司，专注于从哺乳动物细胞培养物中提取的生物制药产品的开发和现行良好生产规范。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409035003861e3fbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409035003861e3fbf&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avidbio.com","stockEarnings":[{"period":"1week","weight":0.1422},{"period":"1month","weight":0.1388},{"period":"3month","weight":0.127},{"period":"6month","weight":0.2427},{"period":"1year","weight":-0.5704},{"period":"ytd","weight":0.1738}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avid Bioservices, Inc.最初于1981年6月在美国加州注册成立，并于1996年9月25日在美国特拉华州重新合并。该公司是一家专门的合同开发和制造组织（“CDMO”），提供从工艺开发到当前良好制造实践的全方位服务（“CGMP”）临床和商业制造，专注于从哺乳动物细胞培养中提取生物制药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.633333,"avgChangeRate":0.252871},{"month":2,"riseRate":0.566667,"avgChangeRate":0.058259},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.035156},{"month":4,"riseRate":0.4,"avgChangeRate":-0.032334},{"month":5,"riseRate":0.5,"avgChangeRate":0.110652},{"month":6,"riseRate":0.433333,"avgChangeRate":0.011938},{"month":7,"riseRate":0.3,"avgChangeRate":0.025373},{"month":8,"riseRate":0.333333,"avgChangeRate":0.002245},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.050651},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.037904},{"month":11,"riseRate":0.533333,"avgChangeRate":0.068059},{"month":12,"riseRate":0.4,"avgChangeRate":0.024422}],"exchange":"NASDAQ","name":"Avid Bioservices, Inc.","nameEN":"Avid Bioservices, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avid Bioservices, Inc.,CDMO,Avid Bioservices, Inc.股票,Avid Bioservices, Inc.股票老虎,Avid Bioservices, Inc.股票老虎国际,Avid Bioservices, Inc.行情,Avid Bioservices, Inc.股票行情,Avid Bioservices, Inc.股价,Avid Bioservices, Inc.股市,Avid Bioservices, Inc.股票价格,Avid Bioservices, Inc.股票交易,Avid Bioservices, Inc.股票购买,Avid Bioservices, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avid Bioservices, Inc.(CDMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avid Bioservices, Inc.(CDMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}